The WHO's July 4 situation report confirmed at least 506 deaths and 1,561 confirmed cases of Ebola in the Democratic Republic of Congo — the clearest numerical signal yet of how far this epidemic has run since it was officially declared on May 15, 2026. Congolese health authorities published a matching figure on July 5, per CGTN Africa, corroborating the WHO data independently.

This is the country's 17th Ebola epidemic, and its pace is without precedent. The WHO stated publicly that the first month alone was the worst on record for any Ebola outbreak in DRC. The pathogen is the Bundibugyo virus (BDBV) — a distinct species within the Orthoebolavirus genus — for which no licensed vaccine and no approved therapeutic exist. That changes the calculus of outbreak response entirely compared to the Sudan or Zaire strain episodes where ring vaccination with rVSV-ZEBOV or the mAb114/REGN-EB3 cocktail were available.

The Geography of Risk

The epidemic originated in the town of Mongbwalu, Ituri province, where the DRC Ministry of Health declared three health zones — Rwampara, Mongwalu, and Bunia — affected from the outset. The Institut National de Recherche Biomédicale (INRB) confirmed 8 positive cases from 13 samples tested on May 14, triggering that declaration. Ituri's overall case-fatality rate now stands at 50.7 percent.

North Kivu province has recorded an even higher CFR: 57.4 percent, a figure Congolese officials have described as "worrying." North Kivu is structurally difficult terrain for outbreak control — years of armed conflict have degraded health infrastructure, disrupted surveillance networks, and eroded community trust in state-led interventions. A CFR above 50 percent in active conflict zones typically signals a combination of late-stage presentation at treatment facilities and incomplete case ascertainment.

Cross-border spread has been limited but not contained. Uganda confirmed two imported cases on May 15 and 16, and as of the most recent reporting the toll there remains at two deaths and 20 confirmed cases — a substantially lower burden, but enough that Uganda's Ministry of Health is operating under elevated alert. The WHO declared a Public Health Emergency of International Concern (PHEIC) on May 16, 2026 — within 24 hours of Uganda's first confirmed import — reflecting the cross-border dimension as much as the DRC case count.

The Pace of Escalation

The numerical trajectory is instructive. By May 21, the WHO's DON603 report recorded only 85 confirmed cases alongside 746 suspected cases. By July 1 — six weeks later — DON612 counted 1,460 confirmed cases and 452 deaths. The July 4 WHO situation report moved the confirmed case count to 1,561 and the death toll to 506. That is roughly 100 additional confirmed cases and 54 additional deaths in three days, a rate of transmission that shows no sign of plateau.

The absence of approved countermeasures has forced a pivot to experimental protocols. A clinical trial evaluating two candidate therapeutics for the Bundibugyo strain began around July 2, according to Al Jazeera. Separately, the WHO granted Emergency Use Listing (EUL) for the first molecular diagnostic test specific to BDBV — a meaningful operational gain, since faster, pathogen-specific PCR confirmation shortens the window between symptom onset and isolation. Africa CDC and WHO jointly launched a Continental Preparedness and Response Plan in early June covering the period through November 2026, and the health ministers of DRC, Uganda, and South Sudan met in Kampala on May 23 to coordinate a regional response framework.

These are not trivial steps. But a clinical trial that launched on July 2 will not yield efficacy data in time to reshape the current trajectory. Therapeutics, even under compassionate use protocols, require manufacturing scale, cold-chain logistics, and trained staff to administer safely — all of which are constrained in the affected zones.

The broader framing here matters for how international partners allocate resources. The previous DRC Ebola outbreak ended in December 2025 — less than six months before this one was declared. Back-to-back epidemics stress surveillance systems, exhaust community health workers, and deplete national stockpiles. The fact that this outbreak involves a strain with no off-the-shelf medical countermeasures, spreading in an active conflict zone, with a CFR above 50 percent in its most affected province, places it in a different operational category from any DRC Ebola response mounted in the past decade. The 500-death milestone is not a ceiling. The epidemiological curve has not turned.